Payden & Rygel’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-600
Closed -$51K 124
2020
Q4
$51K Hold
600
﹤0.01% 128
2020
Q3
$46K Hold
600
﹤0.01% 114
2020
Q2
$44K Hold
600
﹤0.01% 107
2020
Q1
$40K Hold
600
﹤0.01% 107
2019
Q4
$41K Hold
600
﹤0.01% 113
2019
Q3
$44K Hold
600
﹤0.01% 110
2019
Q2
$43K Hold
600
﹤0.01% 111
2019
Q1
$41K Hold
600
﹤0.01% 111
2018
Q4
$36K Hold
600
﹤0.01% 112
2018
Q3
$40K Hold
600
﹤0.01% 110
2018
Q2
$39K Hold
600
﹤0.01% 109
2018
Q1
$43K Hold
600
﹤0.01% 110
2017
Q4
$45K Hold
600
﹤0.01% 110
2017
Q3
$44K Hold
600
﹤0.01% 110
2017
Q2
$44K Hold
600
﹤0.01% 101
2017
Q1
$44K Hold
600
﹤0.01% 105
2016
Q4
$39K Hold
600
﹤0.01% 106
2016
Q3
$44K Hold
600
﹤0.01% 98
2016
Q2
$44K Hold
600
0.01% 97
2016
Q1
$42K Sell
600
-223
-27% -$14.8K 0.01% 102
2015
Q4
$55K Buy
823
+223
+37% +$14.8K 0.01% 109
2015
Q3
$38K Hold
600
0.01% 114
2015
Q2
$39K Hold
600
0.01% 120
2015
Q1
$42K Hold
600
0.01% 126
2014
Q4
$42K Hold
600
0.01% 121
2014
Q3
$39K Hold
600
0.01% 127
2014
Q2
$41K Hold
600
0.01% 129
2014
Q1
$39K Hold
600
0.02% 125
2013
Q4
$39K Hold
600
0.01% 166
2013
Q3
$36K Hold
600
0.01% 149
2013
Q2
$34K Buy
+600
New +$35.6K 0.01% 145

Other funds holding CL

Payden & Rygel's CL Position: Q1 2021 in Review

Payden & Rygel sold out of Colgate-Palmolive (CL) in Q1 2021, closing a stake of 600 shares — an estimated $51K sold.

Payden & Rygel first reported a position in CL in Q2 2013 and held it in 31 quarters. The position peaked at $55K in Q4 2015. 1,608 funds tracked by Wall St. Rank hold CL as of Q1 2021.

  • Payden & Rygel reported no remaining Colgate-Palmolive position as of Q1 2021 after selling out during the quarter.
  • Payden & Rygel sold 600 Colgate-Palmolive shares in Q1 2021, an estimated $51K.
  • Payden & Rygel first reported a position in Colgate-Palmolive in Q2 2013 and held it in 31 quarters.
  • Payden & Rygel's Colgate-Palmolive position peaked at $55K in Q4 2015.
  • 1,608 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2021.

Based on Payden & Rygel's 13F filing for Q1 2021, filed 13 May 2021.